Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

Jean‐Yves Douillard, Rafael Rosell, Mario De Lena, +19

The Lancet Oncology

Surgical OncologyCisplatin Versus ObservationMedicineMetronomic TherapyClinical Trials +8

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Naiyer A. Rizvi, Julien Mazières, David Planchard, +27

The Lancet Oncology

Checkmate 063Single-arm TrialMedicineImmunologyImmune Checkpoint Inhibitor +6

Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

David Planchard, Tae Min Kim, Julien Mazières, +16

The Lancet Oncology

OncologyNon-small-cell Lung CancerPathologyBronchial NeoplasmImmune Checkpoint Inhibitor +5

Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis

David Planchard, Benjamin Besse, Harry J.M. Groen, +14

Journal of Thoracic Oncology

Primary sarcomas of the lung

B. Étienne-Mastroïanni, L. Falchero, Lara Chalabreysse, +4

Lung Cancer

Primary SarcomasPulmonary PathologySurgical PathologyHistopathologyPathology +4

Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy.

Charles Dumontet, Sylvie Isaac, Pierre‐Jean Souquet, +6

PubMed

Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial

Jürgen Wolf, Maximilian J. Hochmair, Ji‐Youn Han, +23

The Lancet Oncology

Geometry Mono-1 TrialMedicinePathologyCancer TreatmentCancer Genetics +6

Intra-Thoracic Chemo-Hyperthermia for pleural recurrence of thymoma

Jean‐Michel Maury, Nicolas Girard, Mayeul Tabutin, +8

Lung Cancer

HyperthermiaMedicinePleural EffusionPleural DiseaseThoracic Surgery +3

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study

Gilles Freyer, Brigitte Tranchand, Blandine Ligneau, +8

British Journal of Clinical Pharmacology

Staging of nutrition disorders in non‐small‐cell lung cancer patients: utility of skeletal muscle mass assessment

S. Antoun, Hugues Morel, Pierre‐Jean Souquet, +8

Journal of Cachexia Sarcopenia and Muscle